Publication details

FEIBA(R) in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre

Authors

SMEJKAL Petr BRABEC Petr MATÝŠKOVÁ Miloslava BULIKOVÁ Alena ŠLECHTOVÁ Marie KISSOVÁ Jarmila CHLUPOVÁ Gabriela MUŽÍK Jan PENKA Miroslav

Year of publication 2009
Type Article in Periodical
Magazine / Source Haemophilia
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords haemophilia; bleeding; FEIBA
Description FEIBA(R) is used to achieve haemostasis in haemophiliacs with inhibitor. The aim of this study was to evaluate efficacy and consumption of the product in treatment of haemorrhages in haemophiliacs with factor VIII inhibitor, and determine factors that can influence the results of treatment. We used data from our haemophilia centre from years 2000-2008. Six haemophiliacs with factor VIII inhibitor were treated on demand with FEIBA(R) for 61 bleeding episodes (45 haemarthroses, six muscle bleeds, six other sites bleeds and four multiple sites bleeds).

You are running an old browser version. We recommend updating your browser to its latest version.

More info